Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
In 18 States, alcohol exclusion laws are still in effect.
2.
Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.
3.
Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer
4.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
5.
Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type
1.
Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide
2.
Risk Assessment of Cancer-Associated Thrombotic Events
3.
Preventing Developmental Iron Depletion in Childhood
4.
Risk Assessment of Cancer-Associated Endocrine Disorders
5.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
4.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
5.
Understanding Blood Clotting Disorders
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation